Skip to main content

Table 2 Endpoint breadth used for different drug management tool categories

From: Systematic review on quality control for drug management programs: Is quality reported in the literature?

Number of Endpoints 1 2 3 4 5 Number of Studies Average No. of Endpoints St. Dev
Drug Management Tool Category         
Financial responsibility to patient 16 8 13 4 2 43 2.3 1.2
Limit access to non-preferred agents 17 12 8 2 1 40 2.0 1.0
Stimulate switch to preferred agents 6 2 0 0 0 8 1.3 0.5
All Drug Management Programs 29 20 18 6 3   2.1 1.1
  1. Analysis by number of endpoints included in the studies in each drug management tool category (n = 76)